Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record.

Multiple Receptors Involved in Peripheral α2, μ, and A1Antinociception, Tolerance, and Withdrawal

Open access
Aley, K. O., Levine, Jon D.·1997·The Journal of Neuroscience

Abstract

We examined the interactions among three classes of peripherally-acting antinociceptive agents (μ-opioid, α 2-adrenergic, and A 1-adenosine) in the development of tolerance and dependence to their antinociceptive effects. Antinociception was determined by assessing the degree of inhibition of prostaglandin E 2(PGE 2)-induced mechanical hyperalgesia, using the Randall-Selitto paw-withdrawal test. Tolerance developed within 4 hr to the antinociceptive effect of the α 2-adrenergic agonist clonidine; dependence also occurred at that time, demonstrated as a withdrawal hyperalgesia that was precipitated by the α 2-receptor antagonist yohimbine. These findings are similar to those reported previously for tolerance and dependence to μ and A 1 peripheral antinociception (Aley et al., 1995). Furthermore, cross-tolerance and cross-withdrawal between μ, A 1, and α 2 agonists occurred. The observations of cross-tolerance and cross-withdrawal suggest that all three receptors are located on the same primary afferent nociceptors. In addition, the observations suggest that the mechanisms of tolerance and dependence to the antinociceptive effects of μ, A 1, and α 2 are mediated by a common mechanism. Although any of the agonists administered alone produce antinociception, we found that μ, A 1, and α 2 receptors may not act independently to produce antinociception, but rather may require the physical presence of the other receptors to produce antinociception by any one agonist. This was suggested by the finding that clonidine (α 2-agonist) antinociception was blocked not only by yohimbine (α 2-antagonist) but also by PACPX (A 1-antagonist) and by naloxone (μ-antagonist), and that DAMGO (μ-agonist) antinociception and CPA (A 1-agonist) antinociception were blocked not only by naloxone (μ-antagonist) and PACPX (A 1-antagonist), respectively, but also by yohimbine (α 2-antagonist). This cross-antagonism of antinociception occurred at the ID 80 dose for each antagonist at its homologous receptor. To test the hypothesis that the physical presence of μ-opioid receptor is required not only for μ antinociception but also for α 2 antinociception, antisense oligodeoxynucleotides (ODNs) for the μ-opioid and α 2C-adrenergic receptors were administered intrathecally to reduce the expression of these receptors on primary afferent neurons. These studies demonstrated that μ-opioid ODN administration decreased not only μ-opioid but also α 2-adrenergic antinociception; A 1 antinociception was unaffected. In contrast, α 2C-adrenergic ODN decreased antinociception induced by all three classes of antinociceptive agents. In conclusion, these data suggest that peripheral antinociception induced by μ, α 2, and A 1 agonists requires the physical presence of multiple receptors. We propose that there is a μ, A 1, α 2 receptor complex mediating antinociception in the periphery. In addition, there is cross-tolerance and cross-dependence between μ, A 1, and α 2 antinociception, suggesting that their underlying mechanisms are related.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.17-02-00735.1997

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 170

Metadata

Authors
Aley, K. O., & Levine, J. D.
Venue
The Journal of Neuroscience
Published
1997-01-15
Volume
17
Issue
2
Pages
735-744
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1849463791
Cited by
170
References
0
FWCI
4.21
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple Receptors Involved in Peripheral α2, μ, and A1Antinociception, Tolerance, and Withdrawal. https://app.cochat.ai/papers/10.1523/jneurosci.17-02-00735.1997
The paper
Aley, K. O., & Levine, J. D. (1997). Multiple Receptors Involved in Peripheral α2, μ, and A1Antinociception, Tolerance, and Withdrawal. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.17-02-00735.1997

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.